Organo (6368) Q1 2025 earnings summary

Executive summary

• Orders received surged 56.9% year-over-year to ¥52,710 million, driven by large-scale projects in the electronics sector and robust demand across general industry and social infrastructure.

• Net sales rose 6.8% year-over-year to ¥31,619 million, with operating profit up 39.8% to ¥4,001 million and profit attributable to owners of parent up 67.5% to ¥2,676 million.

• The order backlog as of June 30, 2024, increased 13.5% year-over-year to ¥139,269 million.

Financial highlights

• Gross profit for the quarter was ¥9,859 million, up from ¥8,102 million year-over-year.

• Ordinary profit increased 40.8% year-over-year to ¥4,368 million.

• Basic earnings per share rose to ¥58.25 from ¥34.81 year-over-year.

• Comprehensive income for the quarter was ¥3,313 million, up 64.1% year-over-year.

Outlook and guidance

• Full-year net sales forecast revised upward to ¥160,000 million (up 6.4% year-over-year), with operating profit forecast at ¥24,500 million (up 8.7%) and profit attributable to owners of parent at ¥17,600 million (up 1.7%).

• Six-month forecast also revised upward, reflecting strong capital investment in the electronics industry and robust service and performance product sales.

• Dividend forecast for the year raised to ¥106.00 per share.